BAL Pharma Limited fabricates and markets pharmaceutical formulations and dynamic pharmaceutical fixings (APIs) in India and globally. The organization offers physician recommended drugs, generics, OTC items, intravenous imbuement items, and mass actives.
It gives hostile to infectives, torment the executives, respiratory consideration, and ladies' wellbeing items under the Aziwin, eBay, Balvibe, MNF, Ocium, and Monogesic In addition to Gel brands; diabetic consideration items under the Diabend and Diabend M Gathering brands; natural/ayurvedic arrangements focusing on conditions, for example, prostate amplification, renal calculi, male fruitlessness, ladies wellbeing, and so forth under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; and cardiovascular consideration items under the Mystery and Administration brands.
The organization likewise offers a scope of APIs for helpful territories, for example, hostile to histamine, platelet inhibitor, against diabetic, anticonvulsant, urinary incontinence, neuropathic torment, hostile to sensitivity, mitigating, diuretic, skin inflammation treatment, and so forth.; and different details. Likewise, it takes part in the treatment of gastrointestinal issues; and heaps, fistula, and obstruction.
SYMBOL
BSE: BALPHARMA.BO
BALPHARMA.BO ₹43.50
Range: 43.00 - 44.9052
Week range: 24.10 - 54.10
Volume: ₹204.00
Shares outstanding: 14.17
Market cap: ₹616.50M
NSE: BALPHARMA.NS
BALPHARMA.NS ₹42.55
Range
|
41.60 - 43.80
|
52-week range
|
23.00 - 54.00
|
Volume
|
₹3.10K
|
Shares outstanding
|
14.17M
|
Market cap
|
₹596.66M
|
Comments
Post a Comment